GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Siegfried Holding AG (XSWX:SFZN) » Definitions » 3-Year EPS without NRI Growth Rate

Siegfried Holding AG (XSWX:SFZN) 3-Year EPS without NRI Growth Rate : 20.80% (As of Dec. 2023)


View and export this data going back to 1973. Start your Free Trial

What is Siegfried Holding AG 3-Year EPS without NRI Growth Rate?

Siegfried Holding AG's EPS without NRI for the six months ended in Dec. 2023 was CHF15.96.

During the past 12 months, Siegfried Holding AG's average EPS without NRI Growth Rate was 0.60% per year. During the past 3 years, the average EPS without NRI Growth Rate was 20.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 20.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 12.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Siegfried Holding AG was 453.80% per year. The lowest was -78.80% per year. And the median was 19.20% per year.


Competitive Comparison of Siegfried Holding AG's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Siegfried Holding AG's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Siegfried Holding AG's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Siegfried Holding AG's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Siegfried Holding AG's 3-Year EPS without NRI Growth Rate falls into.



Siegfried Holding AG 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Siegfried Holding AG  (XSWX:SFZN) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Siegfried Holding AG 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Siegfried Holding AG's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Siegfried Holding AG (XSWX:SFZN) Business Description

Traded in Other Exchanges
Address
Untere Bruehlstrasse 4, Zofingen, CHE, CH-4800
Siegfried Holding AG is a biotechnology company that focuses on primary and secondary drug manufacturing. The company develops and manufactures active pharmaceutical ingredients for pharmaceutical clients with research and development programs, related intermediates, and controlled substances. Siegfried also offers the development and production of finished dosage forms, including sterile fillings. The company broadly offers complex oral and sterile formulations of drug products available for custom development and manufacturing, as well as licensing.

Siegfried Holding AG (XSWX:SFZN) Headlines

No Headlines